Sotera Health (NASDAQ:SHC) Downgraded to Buy Rating by Wall Street Zen

Key Points

• Wall Street Zen downgraded Sotera Health from "strong-buy" to "buy"; the stock's consensus remains a Moderate Buy with an average analyst target of $20.43 (8 Buy, 3 Hold).
• Sotera beat Q4 estimates with $0.26 EPS (vs. $0.24) and $303.44M revenue (vs. $300.68M), raised FY2026 EPS guidance to $0.93–1.01, and currently trades near $15.36 with a ~$4.38B market cap and ~57 P/E.
• GTCR Investment XI LLC sold 10,000,000 shares at about $15.27 (~$152.7M), cutting its ownership by roughly 44% while insiders still hold a sizeable stake.

Sotera Health (NASDAQ:SHC - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating in a research note issued to investors on Saturday.

SHC has been the subject of several other reports. Zacks Research lowered Sotera Health from a "strong-buy" rating to a "hold" rating in a report on Friday, January 30th. Piper Sandler upgraded shares of Sotera Health from a "neutral" rating to an "overweight" rating and upped their price objective for the stock from $17.00 to $24.00 in a report on Friday, January 9th. Citigroup upped their price objective on shares of Sotera Health from $21.00 to $23.00 and gave the stock a "buy" rating in a report on Tuesday, February 24th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Sotera Health in a report on Monday, December 29th. Finally, William Blair assumed coverage on shares of Sotera Health in a report on Thursday, December 18th. They issued an "outperform" rating for the company. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Sotera Health currently has an average rating of "Moderate Buy" and a consensus target price of $20.43.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $15.36 on Friday. The company has a current ratio of 2.46, a quick ratio of 2.24 and a debt-to-equity ratio of 3.66. Sotera Health has a 1 year low of $10.05 and a 1 year high of $19.85. The business has a fifty day simple moving average of $15.52 and a 200 day simple moving average of $16.49. The firm has a market cap of $4.38 billion, a price-to-earnings ratio of 56.89 and a beta of 1.88.

Sotera Health (NASDAQ:SHC - Get Free Report) last announced its quarterly earnings data on Tuesday, February 24th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The business had revenue of $303.44 million during the quarter, compared to analyst estimates of $300.68 million. During the same period last year, the company earned $0.21 earnings per share. Sotera Health's quarterly revenue was up 4.6% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. As a group, sell-side analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company's stock in a transaction on Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the sale, the director directly owned 12,735,301 shares in the company, valued at approximately $194,468,046.27. This represents a 43.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 47.55% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Hsbc Holdings PLC acquired a new position in Sotera Health during the 4th quarter worth $833,000. Corient Private Wealth LLC lifted its position in Sotera Health by 217.4% during the 4th quarter. Corient Private Wealth LLC now owns 44,342 shares of the company's stock worth $773,000 after acquiring an additional 30,373 shares during the last quarter. Pacer Advisors Inc. lifted its position in Sotera Health by 38.8% during the 4th quarter. Pacer Advisors Inc. now owns 32,173 shares of the company's stock worth $568,000 after acquiring an additional 8,993 shares during the last quarter. Kera Capital Partners Inc. acquired a new position in Sotera Health during the 4th quarter worth $339,000. Finally, Invesco Ltd. lifted its position in Sotera Health by 53.9% during the 4th quarter. Invesco Ltd. now owns 519,695 shares of the company's stock worth $9,167,000 after acquiring an additional 182,069 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Company Profile

Sotera Health Inc NASDAQ: SHC is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.